spacer
The Healthcare Sales & Marketing Network celebrates 22 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Momenta Pharmaceuticals 

 HSMN NewsFeed - 13 Feb 2018
Sandoz announces US FDA approval and launch of Glatopa(R) 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 9 Feb 2017
Syndax Appoints Richard P. Shea as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Sep 2016
Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 18 Sep 2015
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 20 Aug 2015
Arch Therapeutics Appoints James Sulat to Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 12 Dec 2013
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2012
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
Biopharmaceuticals Generics Neurology Litigation
 HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jan 2011
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2011
Momenta Pharmaceuticals Appoints Young T. Kwon as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2010
Teva Comments on Patent Infringement Lawsuit Filed by Momenta and Sandoz
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Dec 2010
Momenta Pharmaceuticals Sues Teva for Patent Infringement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Oct 2010
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Jun 2010
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2009
aTyr Pharma Raises an Additional $12 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jun 2009
I-Therapeutix, Inc. Closes $15 Million Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2009
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Aug 2008
Follica Announces $11M in New Financing and Expanded Team
Devices Personnel Venture Capital
 HSMN NewsFeed - 11 Jul 2008
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement
Biopharmaceuticals Generics Neurology FDA Litigation
 HSMN NewsFeed - 11 Jul 2008
Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application With a Paragraph IV Certification for Generic Version of Copaxone
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 4 Mar 2008
Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 27 Nov 2007
BIND Biosciences, Inc. Closes $16M Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Nov 2007
Momenta Pharmaceuticals Announces Receipt of FDA Letter -- M-Enoxaparin ANDA Not Approvable in Current Form
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Oct 2007
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2007
Momenta Pharmaceuticals Announces Executive Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2007
Phreesia Secures $10.25M Series B Funding
Devices Venture Capital
 HSMN NewsFeed - 1 May 2007
Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 10 Apr 2007
Bernard Haffey Appointed President and CEO of NDO Surgical
Devices Gastroenterology Personnel Venture Capital
 HSMN NewsFeed - 21 Dec 2006
Momenta Pharmaceuticals Announces Executive Promotion
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2006
Momenta Pharmaceuticals Announces Appointment of Craig A. Wheeler as Chief Executive Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
Momenta Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.